Over-expression of miR-217 regulates EZH2 to promote osteogenic differentiation of BM-MSCs in osteoporotic mouse models

doi:10.16352/j.issn.1001-6325.2022.09.1406

Abstract

Abstract: Objective To explore the effect of microRNA-217 (miR-217) on the osteogenic differentiation of bone marrow mesenchymal stem cells (BM-MSCs) in osteoporosis (OP) mouse model and potential regulatory mechanism. Methods The mice were divided into OP group and sham operation (sham) group with 12 in each group and both underwent bilateral oophorectomy. The OP mouse BM-MSCs were divided into control group, miR-NC group, miR-217mimics group, miR-217 mimics+pcDNA 3.1 group and miR-217 mimics+pcDNA 3.1-EZH2(enhancer of zeste homologe 2) group. The different groups were treated by transfection with miR-NC, miR-217 mimics, miR-217 mimics plus pcDNA 3.1, miR-217 mimics plus pcDNA 3.1-EZH2 respectively and then followed by osteogenic differentiation. The mRNA and protein expressions of miR-217, EZH2, OCN, Runx2, and collagen Ⅰ were detected by RT-qPCR/Western blot; The alkaline phosphatase (ALP) activity of BM-MSCs in each group was detected by microplate reader; Alizarin red S (ARS) staining assay was used to stain the BM-MSCs in each group for microscopy; The targeting relationship between miR-217 and EZH2 was verified by the dual luciferase reporter gene. Results The expression level of miR-217 in the bone tissue and BM-MSCs of the OP group was lower than that of the sham group (P＜0.05), and the expression level of EZH2 mRNA was higher than that of the sham group(P＜0.05). The expression level of miR-217 in BM-MSCs, the expression levels of OCN, Runx2, collagen Ⅰ mRNAs and proteins, and the ALP activity in the miR-217 mimics group were higher than those in the control group and in miR-NC group (P＜0.05). The expression level of EZH2 mRNA and protein were lower than those of the control group and miR-NC group (P＜0.05). And the degree of ARS staining was heavier than that of the control group and miR-NC group. The expression levels of EZH2 mRNA and protein in BM-MSCs in the miR-217 mimics+pcDNA 3.1-EZH2 group were higher than those in the miR-217 mimics group and miR-217 mimics+pcDNA 3.1 group (P＜0.05). And the expression levels of OCN, Runx2, collagen Ⅰ mRNAs and proteins, and ALP activity were lower than those in miR-217 mimics group and miR-217 mimics+pcDNA 3.1 group (P＜0.05). The degree of ARS staining was lighter than that in miR-217 mimics group and miR-217 mimics+pcDNA 3.1 group. There were binding sites between miR-217 and the 3′UTR region of EZH2 mRNA. The relative luciferase activity of WT-EZH2+miR-217 mimics group was lower than that of WT-EZH2+miR-NC group (P＜0.05). Conclusions Over-expression of miR-217 can inhibit the expression of EZH2 and promote the osteogenic differentiation of BM-MSCs in OP mice, which could provide a new strategy for clinical prevention and treatment of OP.

Key words: microRNA-217, enhancer of zeste homolog 2(EZH2), bone marrow derived mesenchymal stem cell(BM-MSC), osteoporosis

CLC Number:

R681

RUAN Feng, LI He-wei, GONG Yan-lin, LIU Jia-li, LIU Ping. Over-expression of miR-217 regulates EZH2 to promote osteogenic differentiation of BM-MSCs in osteoporotic mouse models[J]. Basic & Clinical Medicine, 2022, 42(9): 1406-1413.

References 15

[1]	Wang H, Zhao W, Tian QJ, et al. Effect of lncRNA AK023948 on rats with postmenopausal osteoporosis via PI3K/AKT signaling pathway[J]. Eur Rev Med Pharmacol Sci, 2020, 24:2181-2188.
[2]	Zhu YL, Wang S, Ding DG, et al. miR-217 inhibits osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells by binding to Runx2[J]. Mol Med Rep, 2017, 15:3271-3277.
[3]	赵继荣, 杨涛, 赵宁, 等. 杜仲诱导骨髓间充质干细胞成骨分化防治骨质疏松症相关信号通路研究进展[J]. 中国骨质疏松杂志, 2020, 26:1868-1872.
[4]	Song C, Guo Y, Chen F, et al. LncRNA MALAT1 promotes osteogenic differentiation through the miR-217/AKT3 axis: a possible strategy to alleviate osteoporosis[J]. J Gene Med, 2022, 14:3409-3416.
[5]	Dai Z, Jin Y, Zheng J, et al. miR-217 promotes cell proliferation and osteogenic differentiation of BMSCs by targeting DKK1 in steroid-associated osteonecrosis[J]. Biomed Pharmacother, 2019, 109:1112-1119.
[6]	Dudakovic A, Samsonraj RM, Paradise CR, et al. Inhibition of the epigenetic suppressor EZH2 primes osteogenic differentiation mediated by BMP2[J]. J Biol Chem, 2020, 295:7877-7893.
[7]	Huang ZM, Wang H, Ji ZG. CircRNA-100284 activates aurora kinase B by inducing methylation of HSP70 via microRNA-217 to promote proliferation of bladder cancer cells[J]. J Cancer Res Clin Oncol, 2021, 147:703-712.
[8]	孙毅, 张翼飞, 李娜, 等. miR-187-5p对骨髓间充质干细胞成骨分化能力的调控作用[J]. 中国骨质疏松杂志, 2019, 25:1116-1120.
[9]	张楚天, 张文明, 林燕萍, 等. 健骨颗粒含药血清调控miR-141对小鼠骨髓间充质干细胞成骨分化的影响[J]. 中国骨质疏松杂志, 2020, 26:497-501.
[10]	Li ZH, Hu H, Zhang XY, et al. miR-291a-3p regulates the BMSCs differentiation via targeting DKK1 in dexamethasone-induced osteoporosis[J]. Kaohsiung J Med Sci, 2020, 36:35-42.
[11]	Gu H, Xu J, Huang Z, et al. Identification and differential expression of microRNAs in 1, 25-dihydroxyvitamin D3-induced osteogenic differentiation of human adipose-derived mesenchymal stem cells[J]. Am J Transl Res, 2017, 9:4856-4871.
[12]	韦宗勇, 肖展宏, 黎裕明. miR-217在hADSCs增殖与成骨分化中的作用及其机制研究[J]. 海南医学, 2020, 31:1633-1637.
[13]	董凡赫, 寿今豪, 陈宇峰, 等. 重楼皂苷I通过抑制自噬减轻磷酸三钙磨损颗粒诱导成骨细胞损伤的实验研究[J]. 中草药, 2020, 36:791-797.
[14]	Adamik J, Pulugulla SH, Zhang P, et al. EZH2 supports osteoclast differentiation and bone resorption Via epigenetic and cytoplasmic targets[J]. J Bone Miner Res, 2020, 35:181-195.
[15]	Cheng M, Zhou Q. Targeting EZH2 ameliorates the LPS-inhibited PDLSC osteogenesis via Wnt/beta-catenin pathway[J]. Cells Tissues Organs, 2020, 209:227-235.